Intelligent Bio Solutions Inc.
INBS
$1.70
-$0.06-3.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 843.90K | 728.90K | 607.50K | 872.30K | 727.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 843.90K | 728.90K | 607.50K | 872.30K | 727.80K |
| Cost of Revenue | 508.30K | 387.50K | 384.40K | 525.50K | -87.70K |
| Gross Profit | 335.60K | 341.40K | 223.10K | 346.80K | 815.60K |
| SG&A Expenses | 2.72M | 2.41M | 1.81M | 1.95M | 2.67M |
| Depreciation & Amortization | 300.30K | 302.00K | 305.20K | 300.40K | 284.50K |
| Other Operating Expenses | -383.90K | -173.30K | -133.60K | -126.10K | -77.90K |
| Total Operating Expenses | 3.73M | 3.28M | 2.87M | 3.60M | 3.54M |
| Operating Income | -2.88M | -2.55M | -2.26M | -2.73M | -2.81M |
| Income Before Tax | -3.10M | -2.55M | -2.26M | -2.69M | -2.80M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.10M | -2.55M | -2.26M | -2.69M | -2.80M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 12.50K | 7.10K | 7.30K | 9.20K | 11.10K |
| Net Income | -3.09M | -2.54M | -2.25M | -2.69M | -2.78M |
| EBIT | -2.88M | -2.55M | -2.26M | -2.73M | -2.81M |
| EBITDA | -2.64M | -2.32M | -2.02M | -2.48M | -2.58M |
| EPS Basic | -0.44 | -0.44 | -0.50 | -0.70 | -0.92 |
| Normalized Basic EPS | -0.26 | -0.28 | -0.31 | -0.44 | -0.57 |
| EPS Diluted | -0.44 | -0.44 | -0.50 | -0.70 | -0.92 |
| Normalized Diluted EPS | -0.26 | -0.28 | -0.31 | -0.44 | -0.57 |
| Average Basic Shares Outstanding | 7.00M | 5.77M | 4.54M | 3.81M | 3.04M |
| Average Diluted Shares Outstanding | 7.00M | 5.77M | 4.54M | 3.81M | 3.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |